Viveve Medical (VIVE) Competitors $0.0001 0.00 (0.00%) As of 03:51 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock VIVE vs. NMRD, MOTS, UTRS, DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, BRSH, and CTCXWShould you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Nemaura Medical (NMRD), Motus GI (MOTS), Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), Bruush Oral Care (BRSH), and Carmell (CTCXW). These companies are all part of the "medical equipment" industry. Viveve Medical vs. Its Competitors Nemaura Medical Motus GI Minerva Surgical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care Bruush Oral Care Carmell Nemaura Medical (NASDAQ:NMRD) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, community ranking, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends. Does the MarketBeat Community prefer NMRD or VIVE? Viveve Medical received 307 more outperform votes than Nemaura Medical when rated by MarketBeat users. Likewise, 73.70% of users gave Viveve Medical an outperform vote while only 57.14% of users gave Nemaura Medical an outperform vote. CompanyUnderperformOutperformNemaura MedicalOutperform Votes457.14% Underperform Votes342.86% Viveve MedicalOutperform Votes31173.70% Underperform Votes11126.30% Does the media refer more to NMRD or VIVE? In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Viveve Medical'saverage media sentiment score. Company Overall Sentiment Nemaura Medical Neutral Viveve Medical Neutral Which has more volatility and risk, NMRD or VIVE? Nemaura Medical has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Is NMRD or VIVE more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A Viveve Medical N/A N/A N/A Do insiders & institutionals believe in NMRD or VIVE? 4.4% of Nemaura Medical shares are owned by institutional investors. 40.4% of Nemaura Medical shares are owned by insiders. Comparatively, 5.7% of Viveve Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has stronger earnings & valuation, NMRD or VIVE? Viveve Medical has higher revenue and earnings than Nemaura Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$3.02K0.00-$14.14M-$0.39N/AViveve Medical$6.83M0.00N/AN/AN/A SummaryNemaura Medical and Viveve Medical tied by winning 3 of the 6 factors compared between the two stocks. Get Viveve Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VIVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIVE vs. The Competition Export to ExcelMetricViveve MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$3.38B$5.61B$8.62BDividend YieldN/A1.75%5.28%4.18%P/E RatioN/A18.7727.2619.97Price / Sales0.00204.10412.06157.64Price / CashN/A44.0938.2534.64Price / BookN/A3.887.064.69Net IncomeN/A$94.03M$3.24B$248.14M7 Day PerformanceN/A1.18%2.56%2.39%1 Month PerformanceN/A10.79%8.75%6.06%1 Year PerformanceN/A22.18%31.30%13.57% Viveve Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070NMRDNemaura Medical0.9696 of 5 starsN/AN/AN/A$4K$3.02K0.0040MOTSMotus GI0.104 of 5 stars$0.00flatN/A-99.6%$2K$319K0.0030UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160DRTSWAlpha Tau MedicalN/A$0.25+1.0%N/A-4.2%$0.00N/A0.0080Positive NewsGap UpANZUWAnzu Special Acquisition Corp IN/A$0.05-0.2%N/A+22.0%$0.00N/A0.002ATAKWAurora Technology AcquisitionN/A$0.02+10.2%N/A-69.2%$0.00N/A0.00N/AGap DownBBLGWBone BiologicsN/A$13.50-20.1%N/A-67.6%$0.00N/A0.002Gap DownBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011BRSHBruush Oral CareN/A$0.00flatN/A-99.3%$0.00$2.92M0.0011CTCXWCarmellN/A$0.03+6.8%N/AN/A$0.00$32.84K0.0014Gap Up Related Companies and Tools Related Companies Nemaura Medical Competitors Motus GI Competitors Minerva Surgical Competitors Alpha Tau Medical Competitors Anzu Special Acquisition Corp I Competitors Aurora Technology Acquisition Competitors Bone Biologics Competitors Bruush Oral Care Competitors Bruush Oral Care Competitors Carmell Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIVE) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VIVE Stock Free VIVE Stock Alerts